- $3.61bn
- $11.03bn
- $6.22bn
US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings
Brief: Organon Enters Into Agreement To License Miudella®
Organon rises as review finds no issues in past biosimilar purchases
U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National
U.S. STOCKS ON THE MOVE-Iron Mountain, BridgeBio, Old Dominion,
U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical
Organon shares fall after Q4 profit miss
Organon Q4 sales, profit miss estimates on women's health, respiratory products decline
Brief: Organon Q4 Adjusted EPS USD 0.63 Vs. IBES Estimate USD 0.73
India's Sun Pharma-Organon $10 bln deal strategic despite high leverage, say analysts
Brief: Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque
U.S. STOCKS ON THE MOVE-TransAlta, Johnson & Johnson, E.W. Scripps
U.S. STOCKS ON THE MOVE-Sunoco, Albemarle, GE Healthcare Technologies
U.S. STOCKS ON THE MOVE-OSI Systems, AEP, TransAlta
U.S. STOCKS ON THE MOVE- Alphabet, Quantum Computing, Jazz Pharma
Organon rises after US FDA clears first biosimilar for breast cancer
Healthcare products maker Organon beats Q3 profit estimates, cuts FY forecast
Brief: Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94
U.S. STOCKS ON THE MOVE-Akamai Technologies, Enbridge, KKR